Recon: FDA approves Guardian’s blood-based cancer test; Boehringer to acquire biotech Nerio for $1.3B
ReconMichael Mezher
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States